• Another worthwhile Morning newsletter from David Leonhardt of the NYT, riffing on how some therapies for Covid-19 are being underutilized, especially in certain populations. Improving usage and access might improve the persistent mortality of this disease, still averaging almost 400 deaths a day in the U.S. David L. is on leave for a few months; I’ll miss him! A revealing excerpt:
